A 59-year-old with chronic coronary disease and prior MI (LVEF 58%) remains asymptomatic at 18 months. Regarding beta-blockers, current guidance suggests:AContinue indefinitely in all post-MI patients with preserved EFBReassess need beyond 1 year; long-term use without another indication is not recommended to reduce MACECStop immediately at 12 months in all casesDSwitch to non-dihydropyridine CCB for mortality benefitEUse beta-blocker only if LDL-C >100 mg/dLCheck my answer